Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons

American Journal of Pathology

Volumn 182, Issue 2, 2013, Pages 474-484

  Cherra III, Salvatore J ^a   Steer, Erin ^a   Gusdon, Aaron M ^a   Kiselyov, Kirill ^b   Chu, Charleen T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHELATING AGENT; CYSTEINE; GLYCINE; LEUCINE RICH REPEAT KINASE 2; SERINE;

ANIMAL CELL; ARTICLE; AUTOPHAGY; BRAIN CORTEX; CALCIUM CELL LEVEL; CONTROLLED STUDY; DENDRITIC MITOCHONDRION; GENE MUTATION; HOMEOSTASIS; MITOCHONDRION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ANIMALS; AUTOPHAGY; CALCIUM; CALCIUM CHANNELS, L-TYPE; DENDRITES; HOMEOSTASIS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION; MUTANT PROTEINS; MUTATION; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES;

EID: 84872691988     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.10.027     Document Type: Article

References (75)

1. A. Toulouse, and A.M. Sullivan Progress in Parkinson's disease: where do we stand? Prog Neurobiol 85 2008 376 392
2. A. Brice Genetics of Parkinson's disease: lRRK2 on the rise Brain 128 2005 2760 2762
3. E.A. Schon, and S. Przedborski Mitochondria: the next (neurode)generation Neuron 70 2011 1033 1053
4. A.M. Gusdon, J. Zhu, B. Van Houten, and C.T. Chu ATP13A2 regulates mitochondrial bioenergetics through macroautophagy Neurobiol Dis 45 2011 962 972
5. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 2000 1301 1306
6. D. Narendra, A. Tanaka, D.F. Suen, and R.J. Youle Parkin is recruited selectively to impaired mitochondria and promotes their autophagy J Cell Biol 183 2008 795 803
7. A.C. Poole, R.E. Thomas, L.A. Andrews, H.M. McBride, A.J. Whitworth, and L.J. Pallanck The PINK1/Parkin pathway regulates mitochondrial morphology Proc Natl Acad Sci U S A 105 2008 1638 1643
8. R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C.M. Rodrigues, A. Alfonso, C. Steer, L. Liu, S. Przedborski, and B. Wolozin Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans J Biol Chem 280 2005 42655 42668
9. C.T. Chu Diversity in the regulation of autophagy and mitophagy: lessons from Parkinson's disease Parkinsons Dis 2011 2011 789431
10. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795
11. M.P. Mattson Calcium and neurodegeneration Aging Cell 6 2007 337 350
12. E.D. Plowey, S.J. Cherra 3rd, Y.J. Liu, and C.T. Chu Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells J Neurochem 105 2008 1048 1056
13. R.K. Dagda, S.J. Cherra 3rd, S.M. Kulich, A. Tandon, D. Park, and C.T. Chu Loss of pink1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission J Biol Chem 284 2009 13843 13855
14. S. Geisler, K.M. Holmstrom, D. Skujat, F.C. Fiesel, O.C. Rothfuss, P.J. Kahle, and W. Springer PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 Nat Cell Biol 12 2010 119 131
15. A.M. Cuervo, L. Stefanis, R. Fredenburg, P.T. Lansbury, and D. Sulzer Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy Science 305 2004 1292 1295
16. D.J. Klionsky, and S.D. Emr Autophagy as a regulated pathway of cellular degradation Science 290 2000 1717 1721
17. S.J. Cherra 3rd, and C.T. Chu Autophagy in neuroprotection and neurodegeneration: a question of balance Future Neurol 3 2008 309 323
18. J. Alegre-Abarrategui, H. Christian, M.M. Lufino, R. Mutihac, L.L. Venda, O. Ansorge, and R. Wade-Martins LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model Hum Mol Genet 18 2009 4022 4034
19. S.J. Cherra 3rd, S.M. Kulich, G. Uechi, M. Balasubramani, J. Mountzouris, B.W. Day, and C.T. Chu Regulation of the autophagy protein LC3 by phosphorylation J Cell Biol 190 2010 533 539
20. F. Gillardon Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability: a point of convergence in parkinsonian neurodegeneration? J Neurochem 110 2009 1514 1522
21. M. Jaleel, R.J. Nichols, M. Deak, D.G. Campbell, F. Gillardon, A. Knebel, and D.R. Alessi LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity Biochem J 405 2007 307 317
22. Y. Li, W. Liu, T.F. Oo, L. Wang, Y. Tang, V. Jackson-Lewis, C. Zhou, K. Geghman, M. Bogdanov, S. Przedborski, M.F. Beal, R.E. Burke, and C. Li Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease Nat Neurosci 12 2009 826 828
23. D. MacLeod, J. Dowman, R. Hammond, T. Leete, K. Inoue, and A. Abeliovich The familial parkinsonism gene LRRK2 regulates neurite process morphology Neuron 52 2006 587 593
24. L. Parisiadou, C. Xie, H.J. Cho, X. Lin, X.L. Gu, C.X. Long, E. Lobbestael, V. Baekelandt, J.M. Taymans, L. Sun, and H. Cai Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis J Neurosci 29 2009 13971 13980
25. D. Ramonet, J.P. Daher, B.M. Lin, K. Stafa, J. Kim, R. Banerjee, M. Westerlund, O. Pletnikova, L. Glauser, L. Yang, Y. Liu, D.A. Swing, M.F. Beal, J.C. Troncoso, J.M. McCaffery, N.A. Jenkins, N.G. Copeland, D. Galter, B. Thomas, M.K. Lee, T.M. Dawson, V.L. Dawson, and D.J. Moore Dopaminergic neuronal loss: reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2 PLoS One 6 2011 e18568
26. G. Piccoli, S.B. Condliffe, M. Bauer, F. Giesert, K. Boldt, S. De Astis, A. Meixner, H. Sarioglu, D.M. Vogt-Weisenhorn, W. Wurst, C.J. Gloeckner, M. Matteoli, C. Sala, and M. Ueffing LRRK2 controls synaptic vesicle storage and mobilization within the recycling pool J Neurosci 31 2011 2225 2237
27. N. Shin, H. Jeong, J. Kwon, H.Y. Heo, J.J. Kwon, H.J. Yun, C.H. Kim, B.S. Han, Y. Tong, J. Shen, T. Hatano, N. Hattori, K.S. Kim, S. Chang, and W. Seol LRRK2 regulates synaptic vesicle endocytosis Exp Cell Res 314 2008 2055 2065
28. X. Li, J.C. Patel, J. Wang, M.V. Avshalumov, C. Nicholson, J.D. Buxbaum, G.A. Elder, M.E. Rice, and Z. Yue Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S J Neurosci 30 2010 1788 1797
29. S. Gehrke, Y. Imai, N. Sokol, and B. Lu Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression Nature 466 2010 637 641
30. Y. Imai, S. Gehrke, H.Q. Wang, R. Takahashi, K. Hasegawa, E. Oota, and B. Lu Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila EMBO J 27 2008 2432 2443
31. H. Mortiboys, K.K. Johansen, J.O. Aasly, and O. Bandmann Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2 Neurology 75 2010 2017 2020
32. S. Biskup, D.J. Moore, F. Celsi, S. Higashi, A.B. West, S.A. Andrabi, K. Kurkinen, S.W. Yu, J.M. Savitt, H.J. Waldvogel, R.L. Faull, P.C. Emson, R. Torp, O.P. Ottersen, T.M. Dawson, and V.L. Dawson Localization of LRRK2 to membranous and vesicular structures in mammalian brain Ann Neurol 60 2006 557 569
33. K. Venderova, G. Kabbach, E. Abdel-Messih, Y. Zhang, R.J. Parks, Y. Imai, S. Gehrke, J. Ngsee, M.J. Lavoie, R.S. Slack, Y. Rao, Z. Zhang, B. Lu, M.E. Haque, and D.S. Park Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease Hum Mol Genet 18 2009 4390 4404
34. I. Ballesteros-Yáñez, R. Benavides-Piccione, J.P. Bourgeois, J.P. Changeux, and J. DeFelipe Alterations of cortical pyramidal neurons in mice lacking high-affinity nicotinic receptors Proc Natl Acad Sci U S A 107 2010 11567 11572
35. D. Schubert, R. Kötter, H.J. Luhmann, and J.F. Staiger Morphology, electrophysiology and functional input connectivity of pyramidal neurons characterizes a genuine layer va in the primary somatosensory cortex Cereb Cortex 16 2006 223 236
36. J.S. Kang, J.H. Tian, P.Y. Pan, P. Zald, C. Li, C. Deng, and Z.H. Sheng Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation Cell 132 2008 137 148
37. K.J. De Vos, and M.P. Sheetz Visualization and quantification of mitochondrial dynamics in living animal cells Methods Cell Biol 80 2007 627 682
38. M.W. Ward, A.C. Rego, B.G. Frenguelli, and D.G. Nicholls Mitochondrial membrane potential and glutamate excitotoxicity in cultured cerebellar granule cells J Neurosci 20 2000 7208 7219
39. J.J. Lemasters, and V.K. Ramshesh Imaging of mitochondrial polarization and depolarization with cationic fluorophores Methods Cell Biol 80 2007 283 295
40. Y. Kabeya, N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda, E. Kominami, Y. Ohsumi, and T. Yoshimori LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO J 19 2000 5720 5728
41. A.S. Tsvetkov, J. Miller, M. Arrasate, J.S. Wong, M.A. Pleiss, and S. Finkbeiner A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model Proc Natl Acad Sci U S A 107 2010 16982 16987
42. D.J. Klionsky, F.C. Abdalla, H. Abeliovich, R.T. Abraham, A. Acevedo-Arozena, and K. Adeli Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy 8 2012 445 544
43. I. Kim, and J.J. Lemasters Mitophagy selectively degrades individual damaged mitochondria after photoirradiation Antioxid Redox Signal 14 2011 1919 1928
44. K.J. Thomas, M.K. McCoy, J. Blackinton, A. Beilina, M. van der Brug, A. Sandebring, D. Miller, D. Maric, A. Cedazo-Minguez, and M.R. Cookson DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy Hum Mol Genet 20 2011 40 50
45. D.G. Nicholls Mitochondrial calcium function and dysfunction in the central nervous system Biochim Biophys Acta 1787 2009 1416 1424
46. J.L. Werth, and S.A. Thayer Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons J Neurosci 14 1994 348 356
47. J.N. Guzman, J. Sanchez-Padilla, D. Wokosin, J. Kondapalli, E. Ilijic, P.T. Schumacker, and D.J. Surmeier Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 Nature 468 2010 696 700
48. T.H. Murphy, L.A. Blatter, W.G. Wier, and J.M. Baraban Spontaneous synchronous synaptic calcium transients in cultured cortical neurons J Neurosci 12 1992 4834 4845
49. H. Vacher, D.P. Mohapatra, and J.S. Trimmer Localization and targeting of voltage-dependent ion channels in mammalian central neurons Physiol Rev 88 2008 1407 1447
50. M.P. Mattson, M. Gleichmann, and A. Cheng Mitochondria in neuroplasticity and neurological disorders Neuron 60 2008 748 766
51. A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, S. Lincoln, J. Kachergus, M. Hulihan, R.J. Uitti, D.B. Calne, A.J. Stoessl, R.F. Pfeiffer, N. Patenge, I.C. Carbajal, P. Vieregge, F. Asmus, B. Muller-Myhsok, D.W. Dickson, T. Meitinger, T.M. Strom, Z.K. Wszolek, and T. Gasser Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607
52. J.H. Zhu, F. Guo, J. Shelburne, S. Watkins, and C.T. Chu Localization of phosphorylated ERK/MAP kinases to mitochondria and autophagosomes in Lewy body diseases Brain Pathol 13 2003 473 481
53. Z. Li, K. Okamoto, Y. Hayashi, and M. Sheng The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses Cell 119 2004 873 887
54. Y. Yang, K. Fukui, T. Koike, and X. Zheng Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons Eur J Neurosci 26 2007 2979 2988
55. H.C. Cheng, S.R. Kim, T.F. Oo, T. Kareva, O. Yarygina, M. Rzhetskaya, C. Wang, M. During, Z. Talloczy, K. Tanaka, M. Komatsu, K. Kobayashi, H. Okano, N. Kholodilov, and R.E. Burke Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy J Neurosci 31 2011 2125 2135
56. C.H. Ng, S.Z. Mok, C. Koh, X. Ouyang, M.L. Fivaz, E.K. Tan, V.L. Dawson, T.M. Dawson, F. Yu, and K.L. Lim Parkin protects against LRRK2 G2019S mutant-induced dopaminergic neurodegeneration in Drosophila J Neurosci 29 2009 11257 11262
57. S. Saha, M.D. Guillily, A. Ferree, J. Lanceta, D. Chan, J. Ghosh, C.H. Hsu, L. Segal, K. Raghavan, K. Matsumoto, N. Hisamoto, T. Kuwahara, T. Iwatsubo, L. Moore, L. Goldstein, M. Cookson, and B. Wolozin LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans J Neurosci 29 2009 9210 9218
58. T.D. Helton, T. Otsuka, M.C. Lee, Y. Mu, and M.D. Ehlers Pruning and loss of excitatory synapses by the parkin ubiquitin ligase Proc Natl Acad Sci U S A 105 2008 19492 19497
59. P. Gómez-Suaga, B. Luzón-Toro, D. Churamani, L. Zhang, D. Bloor-Young, S. Patel, P.G. Woodman, G.C. Churchill, and S. Hilfiker Leucine-rich repeat kinase 2 regulates autophagy through a calcium-dependent pathway involving NAADP Hum Mol Genet 21 2012 511 525
60. C.S. Chan, J.N. Guzman, E. Ilijic, J.N. Mercer, C. Rick, T. Tkatch, G.E. Meredith, and D.J. Surmeier "Rejuvenation" protects neurons in mouse models of Parkinson's disease Nature 447 2007 1081 1086
61. E. Ilijic, J.N. Guzman, and D.J. Surmeier The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease Neurobiol Dis 43 2011 364 371
62. A. Kupsch, M. Gerlach, S.C. Pupeter, J. Sautter, A. Dirr, G. Arnold, W. Opitz, H. Przuntek, P. Riederer, and W.H. Oertel Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice Neuroreport 6 1995 621 625
63. A. Kupsch, J. Sautter, J. Schwarz, P. Riederer, M. Gerlach, and W.H. Oertel 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level Brain Res 741 1996 185 196
64. C. Yao, R. El Khoury, W. Wang, T.A. Byrd, E.A. Pehek, C. Thacker, X. Zhu, M.A. Smith, A.L. Wilson-Delfosse, and S.G. Chen LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease Neurobiol Dis 40 2010 73 81
65. R.J. Nichols, N. Dzamko, N.A. Morrice, D.G. Campbell, M. Deak, A. Ordureau, T. Macartney, Y. Tong, J. Shen, A.R. Prescott, and D.R. Alessi 14-3-3 Binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization Biochem J 430 2010 393 404
66. D. Chan, A. Citro, J.M. Cordy, G.C. Shen, and B. Wolozin Rac1 protein rescues neurite retraction caused by G2019S leucine-rich repeat kinase 2 (LRRK2) J Biol Chem 286 2011 16140 16149
67. X. Li, Q.J. Wang, N. Pan, S. Lee, Y. Zhao, B.T. Chait, and Z. Yue Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease PLoS One 6 2011 e17153
68. A.B. West, D.J. Moore, S. Biskup, A. Bugayenko, W.W. Smith, C.A. Ross, V.L. Dawson, and T.M. Dawson Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity Proc Natl Acad Sci U S A 102 2005 16842 16847
69. E. Greggio, S. Jain, A. Kingsbury, R. Bandopadhyay, P. Lewis, A. Kaganovich, M.P. van der Brug, A. Beilina, J. Blackinton, K.J. Thomas, R. Ahmad, D.W. Miller, S. Kesavapany, A. Singleton, A. Lees, R.J. Harvey, K. Harvey, and M.R. Cookson Kinase activity is required for the toxic effects of mutant LRRK2/dardarin Neurobiol Dis 23 2006 329 341
70. A.B. West, D.J. Moore, C. Choi, S.A. Andrabi, X. Li, D. Dikeman, S. Biskup, Z. Zhang, K.L. Lim, V.L. Dawson, and T.M. Dawson Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity Hum Mol Genet 16 2007 223 232
71. V.S. Anand, L.J. Reichling, K. Lipinski, W. Stochaj, W. Duan, K. Kelleher, P. Pungaliya, E.L. Brown, P.H. Reinhart, R. Somberg, W.D. Hirst, S.M. Riddle, and S.P. Braithwaite Investigation of leucine-rich repeat kinase 2: enzymological properties and novel assays FEBS J 276 2009 466 478
72. C.J. Gloeckner, A. Schumacher, K. Boldt, and M. Ueffing The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro J Neurochem 109 2009 959 968
73. B. Lovitt, E.C. Vanderporten, Z. Sheng, H. Zhu, J. Drummond, and Y. Liu Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2) Biochemistry 49 2010 3092 3100
74. A. Kumar, E. Greggio, A. Beilina, A. Kaganovich, D. Chan, J.M. Taymans, B. Wolozin, and M.R. Cookson The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation PLoS One 5 2010 e8730
75. E. Ohta, F. Kawakami, M. Kubo, and F. Obata LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations FEBS Lett 585 2011 2165 2170